ADME Toxicology Testing Market: Global Trends, Growth, and Industry Outlook

The ADME Toxicology Testing Market is becoming an increasingly important component of pharmaceutical and biotechnology research. ADME testing evaluates how drugs are absorbed, distributed, metabolized, and excreted, while toxicology testing helps identify potential safety concerns during drug development.

According to Market Research Future, the global market was valued at approximately USD 7.12 billion in 2025 and is projected to reach USD 17.48 billion by 2035, expanding at a CAGR of 9.38% during 2026–2035.

The market is benefiting from increasing pharmaceutical R&D spending, regulatory acceptance of non-animal testing methods, advances in artificial intelligence, and growing adoption of in vitro and in silico testing technologies.

Cell culture technology represents a major portion of the market, while in-silico testing is identified as one of the fastest-growing methods. Organ-on-chip platforms, 3D cell cultures, molecular imaging, and AI-based prediction models are also transforming preclinical drug development.

North America currently leads the market, while Asia-Pacific is expected to experience strong growth as pharmaceutical research, CRO capabilities, and biotechnology infrastructure continue to expand.

Read More
Lukoon https://lukoon.com